PATIENT-DERIVED XENOGRAFTS MIRROR THE PROTEOMIC PROFILE OF HUMAN GLIOBLASTOMA: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT

被引：0
|
作者：
Kwatra, Madan M. [1 ]
Brown, Kristine E. [1 ]
Chagoya, Gustavo [1 ]
Keir, Stephen T. [1 ]
Bigner, Darell D. [1 ]
Sampson, John H. [1 ]
机构：
[1] Duke Univ, Durham, NC 27706 USA
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
10.1093/neuonc/nou208.57
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development
    Brown, Kristine E.
    Chagoya, Gustavo
    Kwatra, Shawn G.
    Yen, Timothy
    Keir, Stephen T.
    Cooter, Mary
    Hoadley, Katherine A.
    Rasheed, Ahmed
    Lipp, Eric S.
    Mclendon, Roger
    Ali-Osman, Francis
    Bigner, Darell D.
    Sampson, John H.
    Kwatra, Madan M.
    JOURNAL OF NEUROCHEMISTRY, 2015, 133 (05) : 730 - 738
  • [2] Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized therapy
    Patrizii, Michele
    Bartucci, Monica
    Pine, Sharon R.
    Sabaawy, Hatem E.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [3] The proteomic characterization of HNSCC patient-derived xenografts
    Li, Hua
    Wheeler, Sarah E.
    Park, Yongseok
    Ju, Zhenlin
    Egloff, Ann Marie
    Fichera, Michele
    Thomas, Sufi
    Mills, Gordon B.
    Grandis, Jennifer R.
    CANCER RESEARCH, 2015, 75
  • [4] Patient-derived xenografts: a relevant preclinical model for drug development
    Luca Pompili
    Manuela Porru
    Carla Caruso
    Annamaria Biroccio
    Carlo Leonetti
    Journal of Experimental & Clinical Cancer Research, 35
  • [5] Patient-derived tumour xenografts as models for oncology drug development
    Tentler, John J.
    Tan, Aik Choon
    Weekes, Colin D.
    Jimeno, Antonio
    Leong, Stephen
    Pitts, Todd M.
    Arcaroli, John J.
    Messersmith, Wells A.
    Eckhardt, S. Gail
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (06) : 338 - 350
  • [6] Patient-derived xenografts: a relevant preclinical model for drug development
    Pompili, Luca
    Porru, Manuela
    Caruso, Carla
    Biroccio, Annamaria
    Leonetti, Carlo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
  • [7] Patient-derived tumour xenografts as models for oncology drug development
    John J. Tentler
    Aik Choon Tan
    Colin D. Weekes
    Antonio Jimeno
    Stephen Leong
    Todd M. Pitts
    John J. Arcaroli
    Wells A. Messersmith
    S. Gail Eckhardt
    Nature Reviews Clinical Oncology, 2012, 9 : 338 - 350
  • [8] CHARACTERIZATION OF PATIENT-DERIVED TUMOR SPHERES AND XENOGRAFTS FOR GLIOBLASTOMA
    Kijima, Noriyuki
    Kanematsu, Daisuke
    Shofuda, Tomoko
    Yoshioka, Ema
    Handa, Yukako
    Moriuchi, Shusuke
    Nonaka, Masahiro
    Okita, Yoshiko
    Tsuyuguchi, Naohiro
    Fukai, Junya
    Higuchi, Yuichiro
    Suemizu, Hiroshi
    Kanemura, Yonehiro
    NEURO-ONCOLOGY, 2017, 19 : 258 - 258
  • [9] Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
    Meneceur, Sarah
    Linge, Annett
    Meinhardt, Matthias
    Hering, Sandra
    Loeck, Steffen
    Buetof, Rebecca
    Krex, Dietmar
    Schackert, Gabriele
    Temme, Achim
    Baumann, Michael
    Krause, Mechthild
    von Neubeck, Claere
    CANCERS, 2020, 12 (04)
  • [10] Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma
    Ratliff, Miriam
    Kim, Hichul
    Qi, Hao
    Kim, Minsung
    Ku, Bosung
    Azorin, Daniel Dominguez
    Hausmann, David
    Khajuria, Rajiv K.
    Patel, Areeba
    Maier, Elena
    Cousin, Loic
    Ogier, Arnaud
    Sahm, Felix
    Etminan, Nima
    Bunse, Lukas
    Winkler, Frank
    El-Khoury, Victoria
    Platten, Michael
    Kwon, Yong-Jun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
12345